424 related articles for article (PubMed ID: 29730322)
1. Salt formation improved the properties of a candidate drug during early formulation development.
Sigfridsson K; Ahlqvist M; Lindsjö M; Paulsson S
Eur J Pharm Sci; 2018 Jul; 120():162-171. PubMed ID: 29730322
[TBL] [Abstract][Full Text] [Related]
2. Early development evaluation of AZD2738, a substrate for the NK receptors.
Sigfridsson K; Ahlqvist M; Lindsjö M; Paulsson S
Drug Dev Ind Pharm; 2011 Jun; 37(6):719-26. PubMed ID: 21323487
[TBL] [Abstract][Full Text] [Related]
3. The crystalline salt form of a selected candidate drug showed photo-, thermal- and humidity induced form transitions.
Sigfridsson K; Lindsjö M; Paulsson S
Eur J Pharm Sci; 2019 Feb; 128():128-136. PubMed ID: 30502453
[TBL] [Abstract][Full Text] [Related]
4. Preformulation evaluation of AZD1305, an oxabispidine intended for oral and intravenous treatment.
Sigfridsson K; Lundqvist R; Ohlson K
Drug Dev Ind Pharm; 2012 Jan; 38(1):19-31. PubMed ID: 21707325
[TBL] [Abstract][Full Text] [Related]
5. Crystal forms of the hydrogen oxalate salt of o-desmethylvenlafaxine.
Dichiarante E; Curzi M; Giaffreda SL; Grepioni F; Maini L; Braga D
J Pharm Pharmacol; 2015 Jun; 67(6):823-9. PubMed ID: 25644936
[TBL] [Abstract][Full Text] [Related]
6. Preparation and characterization of spray-dried co-amorphous drug-amino acid salts.
Jensen KT; Blaabjerg LI; Lenz E; Bohr A; Grohganz H; Kleinebudde P; Rades T; Löbmann K
J Pharm Pharmacol; 2016 May; 68(5):615-24. PubMed ID: 26245703
[TBL] [Abstract][Full Text] [Related]
7. Preparation of an amorphous sodium furosemide salt improves solubility and dissolution rate and leads to a faster Tmax after oral dosing to rats.
Nielsen LH; Gordon S; Holm R; Selen A; Rades T; Müllertz A
Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):942-51. PubMed ID: 24075980
[TBL] [Abstract][Full Text] [Related]
8. Characterization of Solid Dispersion of Itraconazole Prepared by Solubilization in Concentrated Aqueous Solutions of Weak Organic Acids and Drying.
Parikh T; Sandhu HK; Talele TT; Serajuddin AT
Pharm Res; 2016 Jun; 33(6):1456-71. PubMed ID: 26951566
[TBL] [Abstract][Full Text] [Related]
9. Early development evaluation of AZD8081: a substrate for the NK receptors.
Sigfridsson K; Ahlqvist M; Carlsson A; Fridström A
Drug Dev Ind Pharm; 2011 Jun; 37(6):702-13. PubMed ID: 21417618
[TBL] [Abstract][Full Text] [Related]
10. Crystal Structure Analysis of the First Discovered Stability-Enhanced Solid State of Tenofovir Disoproxil Free Base Using Single Crystal X-ray Diffraction.
An JH; Kiyonga AN; Yoon W; Ryu HC; Kim JS; Kang C; Park M; Yun H; Jung K
Molecules; 2017 Jul; 22(7):. PubMed ID: 28708115
[TBL] [Abstract][Full Text] [Related]
11. Crystal structure and physicochemical characterization of ambazone monohydrate, anhydrous, and acetate salt solvate.
Muresan-Pop M; Braga D; Pop MM; Borodi G; Kacso I; Maini L
J Pharm Sci; 2014 Nov; 103(11):3594-3601. PubMed ID: 25187325
[TBL] [Abstract][Full Text] [Related]
12. Preformulation investigation and challenges; salt formation, salt disproportionation and hepatic recirculation.
Sigfridsson K; Nilsson L; Ahlqvist M; Andersson T; Granath AK
Eur J Pharm Sci; 2017 Jun; 104():262-272. PubMed ID: 28366653
[TBL] [Abstract][Full Text] [Related]
13. Solid-state supramolecular synthesis based on the N-H…O heterosynthon: an approach to solve the polymorphism problem in famotidine.
Russo MG; Brusau EV; Ellena J; Narda GE
J Pharm Sci; 2014 Nov; 103(11):3754-3763. PubMed ID: 25277273
[TBL] [Abstract][Full Text] [Related]
14. Crystal growth formation in melt extrudates.
Bruce C; Fegely KA; Rajabi-Siahboomi AR; McGinity JW
Int J Pharm; 2007 Aug; 341(1-2):162-72. PubMed ID: 17524578
[TBL] [Abstract][Full Text] [Related]
15. Continuous Preparation of 1:1 Haloperidol-Maleic Acid Salt by a Novel Solvent-Free Method Using a Twin Screw Melt Extruder.
Lee HL; Vasoya JM; Cirqueira ML; Yeh KL; Lee T; Serajuddin AT
Mol Pharm; 2017 Apr; 14(4):1278-1291. PubMed ID: 28245127
[TBL] [Abstract][Full Text] [Related]
16. Undesired co-amorphisation of indomethacin and arginine during combined storage at high humidity conditions.
Petry I; Löbmann K; Grohganz H; Rades T; Leopold CS
Int J Pharm; 2018 Jun; 544(1):172-180. PubMed ID: 29669257
[TBL] [Abstract][Full Text] [Related]
17. Performance comparison between crystalline and co-amorphous salts of indomethacin-lysine.
Kasten G; Nouri K; Grohganz H; Rades T; Löbmann K
Int J Pharm; 2017 Nov; 533(1):138-144. PubMed ID: 28947246
[TBL] [Abstract][Full Text] [Related]
18. Modification of the solid-state nature of sulfathiazole and sulfathiazole sodium by spray drying.
Bianco S; Caron V; Tajber L; Corrigan OI; Nolan L; Hu Y; Healy AM
AAPS PharmSciTech; 2012 Jun; 13(2):647-60. PubMed ID: 22549223
[TBL] [Abstract][Full Text] [Related]
19. Selection of optimal hydrate/solvate forms of a fibrinogen receptor antagonist for solid dosage development.
Bray ML; Jahansouz H; Kaufman MJ
Pharm Dev Technol; 1999 Jan; 4(1):81-7. PubMed ID: 10027216
[TBL] [Abstract][Full Text] [Related]
20. Cocrystals of acyclovir with promising physicochemical properties.
Sarkar A; Rohani S
J Pharm Sci; 2015 Jan; 104(1):98-105. PubMed ID: 25407552
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
